Opioid Analgesics Market

Market Study on Opioid Analgesics: PMR Predicts Promising Prospects, Analysing the Rising Incidence of Chronic Pain Conditions, Increasing Surgical Procedures, and Rising Application in Post-surgical Pain Management

A Detailed Analysis of the Opioid Analgesics Market Influenced by an Expanding Aging Population, Rising Prevalence of Chronic Pain Conditions, and Advent of Pharmaceutical R&D

Report ID: PMRREP33953

Number of Pages: 189

Format: PPT*, PDF, EXCEL

Industry: Healthcare

Published Date: January-2024

Report Price

$4900*

Buy Now

Table of Content

1. Executive Summary

    1.1. Global Opioid Analgesics Market Snapshot, 2023 and 2030

    1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn

    1.3. Key Market Trends

    1.4. Future Market Projections

    1.5. Premium Market Insights

    1.6. Industry Developments and Key Market Events   

    1.7. PMR Analysis and Recommendations

2. Market Overview

    2.1. Market Scope and Definition

    2.2. Market Dynamics

        2.2.1. Drivers

        2.2.2. Restraints

        2.2.3. Opportunity

        2.2.4. Challenges

        2.2.5. Key Trends

    2.3. Drug Class Lifecycle Analysis

    2.4. Opioid Analgesics Market: Value Chain

        2.4.1. List of Raw Material Supplier

        2.4.2. List of Manufacturers

        2.4.3. List of Distributors

        2.4.4. List of Applications

        2.4.5. Profitability Analysis

    2.5. Porter Five Force's Analysis

    2.6. Geopolitical Tensions: Market Impact   

    2.7. Macro-Economic Factors 

        2.7.1. Global Sectorial Outlook

        2.7.2. Global GDP Growth Outlook

        2.7.3. Global Parent Market Overview

    2.8. Forecast Factors - Relevance and Impact

    2.9. Regulatory and Technology Landscape

3. Global Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    3.1. Key Highlights

        3.1.1. Market Volume (Units) Projections

        3.1.2. Market Size and Y-o-Y Growth

        3.1.3. Absolute $ Opportunity

    3.2. Market Size (US$ Mn) Analysis and Forecast

        3.2.1. Historical Market Size Analysis, 2013-2016

        3.2.2. Current Market Size Forecast, 2018-2026

    3.3. Global Opioid Analgesics Market Outlook: Drug Class

        3.3.1. Introduction / Key Findings

        3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug Class, 2018 - 2022

        3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030

            3.3.3.1. Morphine

            3.3.3.2. Codeine

            3.3.3.3. Fentanyl

            3.3.3.4. Meperidine

            3.3.3.5. Methadone

            3.3.3.6. Tramadol

            3.3.3.7. Oxycodone

            3.3.3.8. Dextromethorphan

            3.3.3.9. Buprenorphine

            3.3.3.10. Others

    3.4. Market Attractiveness Analysis: Drug Class

    3.5. Global Opioid Analgesics Market Outlook: Indication

        3.5.1. Introduction / Key Findings

        3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Indication, 2018 - 2022

        3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030

            3.5.3.1. Surgical Pain

            3.5.3.2. Cancer Pain

            3.5.3.3. Neuropathic Pain

            3.5.3.4. Other

    3.6. Market Attractiveness Analysis: Indication

    3.7. Global Opioid Analgesics Market Outlook: Route of Administration

        3.7.1. Introduction / Key Findings

        3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Route of Administration, 2018 - 2022

        3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

            3.7.3.1. Oral

            3.7.3.2. Parenteral

            3.7.3.3. Transdermal

            3.7.3.4. Other

    3.8. Market Attractiveness Analysis: Route of Administration

    3.9. Global Opioid Analgesics Market Outlook: End User

        3.9.1. Introduction / Key Findings

        3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022

        3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

            3.9.3.1. Hospitals

            3.9.3.2. Retail Pharmacies

            3.9.3.3. Drug Stores

            3.9.3.4. Online Pharmacies

    3.10. Market Attractiveness Analysis: End User

4. Global Opioid Analgesics Market Outlook: Region

    4.1. Key Highlights

    4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022

    4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030

        4.3.1. North America

        4.3.2. Europe

        4.3.3. East Asia

        4.3.4. South Asia and Oceania

        4.3.5. Latin America

        4.3.6. Middle East & Africa (MEA)

    4.4. Market Attractiveness Analysis: Region

5. North America Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030) 

    5.1. Key Highlights

    5.2. Pricing Analysis

    5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        5.3.1. By Country

        5.3.2. By Drug Class

        5.3.3. By Indication

        5.3.4. By Route of Administration 

        5.3.5. By End User

    5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        5.4.1. U.S.

        5.4.2. Canada

    5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030

        5.5.1. Morphine

        5.5.2. Codeine

        5.5.3. Fentanyl

        5.5.4. Meperidine

        5.5.5. Methadone

        5.5.6. Tramadol

        5.5.7. Oxycodone

        5.5.8. Dextromethorphan

        5.5.9. Buprenorphine

        5.5.10. Others

    5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030

        5.6.1. Surgical Pain

        5.6.2. Cancer Pain

        5.6.3. Neuropathic Pain

        5.6.4. Other

    5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        5.7.1. Oral

        5.7.2. Parenteral

        5.7.3. Transdermal

        5.7.4. Other

    5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        5.8.1. Hospitals

        5.8.2. Retail Pharmacies

        5.8.3. Drug Stores

        5.8.4. Online Pharmacies

    5.9. Market Attractiveness Analysis

6. Europe Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    6.1. Key Highlights

    6.2. Pricing Analysis

    6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        6.3.1. By Country

        6.3.2. By Drug Class

        6.3.3. By Indication

        6.3.4. By Route of Administration 

        6.3.5. By End User

    6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        6.4.1. Germany

        6.4.2. France

        6.4.3. U.K.

        6.4.4. Italy

        6.4.5. Spain

        6.4.6. Russia

        6.4.7. Türkiye

        6.4.8. Rest of Europe

    6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030

        6.5.1. Morphine

        6.5.2. Codeine

        6.5.3. Fentanyl

        6.5.4. Meperidine

        6.5.5. Methadone

        6.5.6. Tramadol

        6.5.7. Oxycodone

        6.5.8. Dextromethorphan

        6.5.9. Buprenorphine

        6.5.10. Others

    6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030

        6.6.1. Surgical Pain

        6.6.2. Cancer Pain

        6.6.3. Neuropathic Pain

        6.6.4. Other

    6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        6.7.1. Oral

        6.7.2. Parenteral

        6.7.3. Transdermal

        6.7.4. Other

    6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        6.8.1. Hospitals

        6.8.2. Retail Pharmacies

        6.8.3. Drug Stores

        6.8.4. Online Pharmacies

    6.9. Market Attractiveness Analysis

7. East Asia Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    7.1. Key Highlights

    7.2. Pricing Analysis

    7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        7.3.1. By Country

        7.3.2. By Drug Class

        7.3.3. By Indication

        7.3.4. By Route of Administration 

        7.3.5. By End User

    7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        7.4.1. China

        7.4.2. Japan

        7.4.3. South Korea

    7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030

        7.5.1. Morphine

        7.5.2. Codeine

        7.5.3. Fentanyl

        7.5.4. Meperidine

        7.5.5. Methadone

        7.5.6. Tramadol

        7.5.7. Oxycodone

        7.5.8. Dextromethorphan

        7.5.9. Buprenorphine

        7.5.10. Others

    7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030

        7.6.1. Surgical Pain

        7.6.2. Cancer Pain

        7.6.3. Neuropathic Pain

        7.6.4. Other

    7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        7.7.1. Oral

        7.7.2. Parenteral

        7.7.3. Transdermal

        7.7.4. Other

    7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        7.8.1. Hospitals

        7.8.2. Retail Pharmacies

        7.8.3. Drug Stores

        7.8.4. Online Pharmacies

    7.9. Market Attractiveness Analysis

8. South Asia & Oceania Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    8.1. Key Highlights

    8.2. Pricing Analysis

    8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        8.3.1. By Country

        8.3.2. By Drug Class

        8.3.3. By Indication

        8.3.4. By Route of Administration 

        8.3.5. By End User

    8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        8.4.1. India

        8.4.2. Southeast Asia

        8.4.3. ANZ

        8.4.4. Rest of South Asia & Oceania

    8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030

        8.5.1. Morphine

        8.5.2. Codeine

        8.5.3. Fentanyl

        8.5.4. Meperidine

        8.5.5. Methadone

        8.5.6. Tramadol

        8.5.7. Oxycodone

        8.5.8. Dextromethorphan

        8.5.9. Buprenorphine

        8.5.10. Others

    8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030

        8.6.1. Surgical Pain

        8.6.2. Cancer Pain

        8.6.3. Neuropathic Pain

        8.6.4. Other

    8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        8.7.1. Oral

        8.7.2. Parenteral

        8.7.3. Transdermal

        8.7.4. Other

    8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        8.8.1. Hospitals

        8.8.2. Retail Pharmacies

        8.8.3. Drug Stores

        8.8.4. Online Pharmacies

    8.9. Market Attractiveness Analysis

9. Latin America Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    9.1. Key Highlights

    9.2. Pricing Analysis

    9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        9.3.1. By Country

        9.3.2. By Drug Class

        9.3.3. By Indication

        9.3.4. By Route of Administration 

        9.3.5. By End User

    9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        9.4.1. Brazil

        9.4.2. Mexico

        9.4.3. Rest of Latin America

    9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030

        9.5.1. Morphine

        9.5.2. Codeine

        9.5.3. Fentanyl

        9.5.4. Meperidine

        9.5.5. Methadone

        9.5.6. Tramadol

        9.5.7. Oxycodone

        9.5.8. Dextromethorphan

        9.5.9. Buprenorphine

        9.5.10. Others

    9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030

        9.6.1. Surgical Pain

        9.6.2. Cancer Pain

        9.6.3. Neuropathic Pain

        9.6.4. Other

    9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        9.7.1. Oral

        9.7.2. Parenteral

        9.7.3. Transdermal

        9.7.4. Other

    9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        9.8.1. Hospitals

        9.8.2. Retail Pharmacies

        9.8.3. Drug Stores

        9.8.4. Online Pharmacies

    9.9. Market Attractiveness Analysis

10. Middle East & Africa Opioid Analgesics Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

    10.1. Key Highlights

    10.2. Pricing Analysis

    10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022

        10.3.1. By Country

        10.3.2. By Drug Class

        10.3.3. By Indication

        10.3.4. By Route of Administration 

        10.3.5. By End User

    10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030

        10.4.1. GCC

        10.4.2. Egypt

        10.4.3. South Africa

        10.4.4. Northern Africa

        10.4.5. Rest of Middle East & Africa

    10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Class, 2023 - 2030

        10.5.1. \Morphine

        10.5.2. Codeine

        10.5.3. Fentanyl

        10.5.4. Meperidine

        10.5.5. Methadone

        10.5.6. Tramadol

        10.5.7. Oxycodone

        10.5.8. Dextromethorphan

        10.5.9. Buprenorphine

        10.5.10. Others

    10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Indication, 2023 - 2030

        10.6.1. Surgical Pain

        10.6.2. Cancer Pain

        10.6.3. Neuropathic Pain

        10.6.4. Other

    10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030

        10.7.1. Oral

        10.7.2. Parenteral

        10.7.3. Transdermal

        10.7.4. Other

    10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030

        10.8.1. Hospitals

        10.8.2. Retail Pharmacies

        10.8.3. Drug Stores

        10.8.4. Online Pharmacies

    10.9. Market Attractiveness Analysis

11. Competition Landscape

    11.1. Market Share Analysis, 2022

    11.2. Market Structure

        11.2.1. Competition Intensity Mapping By Market  

        11.2.2. Competition Dashboard

        11.2.3. Apparent Product Capacity

    11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

        11.3.1. Pfizer Inc.

            11.3.1.1. Overview

            11.3.1.2. Segments and Product

            11.3.1.3. Key Financials

            11.3.1.4. Market Developments

            11.3.1.5. Market Strategy

        11.3.2. Abbott Laboratories

            11.3.2.1. Overview

            11.3.2.2. Segments and Product

            11.3.2.3. Key Financials

            11.3.2.4. Market Developments

            11.3.2.5. Market Strategy

        11.3.3. Janssen Pharmaceuticals, Inc. [Johnson & Johnson]

            11.3.3.1. Overview

            11.3.3.2. Segments and Product

            11.3.3.3. Key Financials

            11.3.3.4. Market Developments

            11.3.3.5. Market Strategy

        11.3.4. Novartis AG

            11.3.4.1. Overview

            11.3.4.2. Segments and Product

            11.3.4.3. Key Financials

            11.3.4.4. Market Developments

            11.3.4.5. Market Strategy

        11.3.5. Bayer AG

            11.3.5.1. Overview

            11.3.5.2. Segments and Product

            11.3.5.3. Key Financials

            11.3.5.4. Market Developments

            11.3.5.5. Market Strategy

        11.3.6. GlaxoSmithKline plc

            11.3.6.1. Overview

            11.3.6.2. Segments and Product

            11.3.6.3. Key Financials

            11.3.6.4. Market Developments

            11.3.6.5. Market Strategy

        11.3.7. F. Hoffmann-La Roche AG    

            11.3.7.1. Overview

            11.3.7.2. Segments and Product

            11.3.7.3. Key Financials

            11.3.7.4. Market Developments

            11.3.7.5. Market Strategy

        11.3.8. Boehringer Ingelheim International GmbH

            11.3.8.1. Overview

            11.3.8.2. Segments and Product

            11.3.8.3. Key Financials

            11.3.8.4. Market Developments

            11.3.8.5. Market Strategy

        11.3.9. Bausch Health Companies Inc.

            11.3.9.1. Overview

            11.3.9.2. Segments and Product

            11.3.9.3. Key Financials

            11.3.9.4. Market Developments

            11.3.9.5. Market Strategy

        11.3.10. Sanofi S.A.

            11.3.10.1. Overview

            11.3.10.2. Segments and Product

            11.3.10.3. Key Financials

            11.3.10.4. Market Developments

            11.3.10.5. Market Strategy

        11.3.11. Teva Pharmaceuticals

            11.3.11.1. Overview

            11.3.11.2. Segments and Product

            11.3.11.3. Key Financials

            11.3.11.4. Market Developments

            11.3.11.5. Market Strategy

        11.3.12. AbbVie Inc. (Allergan plc)

            11.3.12.1. Overview

            11.3.12.2. Segments and Product

            11.3.12.3. Key Financials

            11.3.12.4. Market Developments

            11.3.12.5. Market Strategy

        11.3.13. Purdue Pharmaceuticals L.P.

            11.3.13.1. Overview

            11.3.13.2. Segments and Product

            11.3.13.3. Key Financials

            11.3.13.4. Market Developments

            11.3.13.5. Market Strategy

        11.3.14. Sun Pharmaceutical Industries Ltd.

            11.3.14.1. Overview

            11.3.14.2. Segments and Product

            11.3.14.3. Key Financials

            11.3.14.4. Market Developments

            11.3.14.5. Market Strategy

        11.3.15. Mallinckrodt Pharmaceuticals

            11.3.15.1. Overview

            11.3.15.2. Segments and Product

            11.3.15.3. Key Financials

            11.3.15.4. Market Developments

            11.3.15.5. Market Strategy

        11.3.16. Endo Pharmaceuticals Inc. [Endo International plc]

            11.3.16.1. Overview

            11.3.16.2. Segments and Product

            11.3.16.3. Key Financials

            11.3.16.4. Market Developments

            11.3.16.5. Market Strategy

        11.3.17. Assertio Therapeutics, Inc. [Assertio Holdings, Inc.]

            11.3.17.1. Overview

            11.3.17.2. Segments and Product

            11.3.17.3. Key Financials

            11.3.17.4. Market Developments

            11.3.17.5. Market Strategy

12. Appendix

    12.1. Research Methodology

    12.2. Research Assumptions

    12.3. Acronyms and Abbreviations

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate